BVNKF:OTCMKTS
Bavarian Nordic A/S
36,06 $
0,00%
(0,00) 1 p
8. okt, 15:46:25 GMT −4 · USD
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse BVNKF põhistatistika genereerimine…
Turu kapit.
2,86 mld
Keskm. maht
14,00
Maht
0,00
52 näd kõrgeim
37,22 $
52 näd madalaim
27,69 $
Beeta
1,46
Käibivad aktsiad
79,26 mln
Töötajate arv
2 tuh
Turu kapit.
2,86 mld
Keskm. maht
14,00
Maht
0,00
52 näd kõrgeim
37,22 $
52 näd madalaim
27,69 $
Beeta
1,46
Käibivad aktsiad
79,26 mln
Töötajate arv
2 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
GlobeNewswire
·
10 minuti eest
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
Profiil
Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany, as well as offices in USA, Canada, and France. The company uses viral vectors and virus-like particles in its research and development.
In July 2025, the company agreed to be acquired by private equity firms Permira and Nordic Capital for 19 billion kr. However, in November, the acquisition failed to gain sufficient support from Bavarian Nordic's shareholders, leading to its termination.
In 2026, Bavarian Nordic was ranked second in Time Magazine's World Most Impactful Companies. Wikipedia
Teave üksuse Bavarian Nordic A/S kohta
TegevjuhtPaul Chaplin
Töötajad1,91 tuh
Asutatud1. juuli 1992
Peakontorid-
Sektor-
Veebisaitbavarian-nordic.com